View in EDS

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.

Saved in:
Bibliographic Details
Title: Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
Authors: Feduccia AA; Department of Research Development and Regulatory Affairs, MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Feduccia, Jerome). Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, United States (Yazar-Klosinski, Doblin). MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Emerson). Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States (Mithoefer)., Jerome L; Department of Research Development and Regulatory Affairs, MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Feduccia, Jerome). Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, United States (Yazar-Klosinski, Doblin). MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Emerson). Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States (Mithoefer)., Yazar-Klosinski B; Department of Research Development and Regulatory Affairs, MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Feduccia, Jerome). Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, United States (Yazar-Klosinski, Doblin). MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Emerson). Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States (Mithoefer)., Emerson A; Department of Research Development and Regulatory Affairs, MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Feduccia, Jerome). Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, United States (Yazar-Klosinski, Doblin). MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Emerson). Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States (Mithoefer)., Mithoefer MC; Department of Research Development and Regulatory Affairs, MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Feduccia, Jerome). Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, United States (Yazar-Klosinski, Doblin). MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Emerson). Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States (Mithoefer)., Doblin R; Department of Research Development and Regulatory Affairs, MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Feduccia, Jerome). Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, United States (Yazar-Klosinski, Doblin). MAPS Public Benefit Corporation, Santa Cruz, CA, United States (Emerson). Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States (Mithoefer).
Source: Focus (American Psychiatric Publishing) [Focus (Am Psychiatr Publ)] 2023 Jul; Vol. 21 (3), pp. 306-314. Date of Electronic Publication: 2023 Jun 28.
Publication Type: Journal Article; Review
Journal Info: Publisher: American Psychiatric Pub Country of Publication: United States NLM ID: 101156081 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1541-4094 (Print) Linking ISSN: 15414094 NLM ISO Abbreviation: Focus (Am Psychiatr Publ) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1541-4094
DOI:10.1176/appi.focus.23021013